1. Home
  2. LCUT vs ABOS Comparison

LCUT vs ABOS Comparison

Compare LCUT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$7.20

Market Cap

131.2M

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.64

Market Cap

155.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
ABOS
Founded
1945
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
131.2M
155.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
LCUT
ABOS
Price
$7.20
$2.64
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$3.50
$7.75
AVG Volume (30 Days)
283.9K
637.6K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.89
N/A
Revenue Next Year
$1.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$0.86
52 Week High
$7.35
$3.60

Technical Indicators

Market Signals
Indicator
LCUT
ABOS
Relative Strength Index (RSI) 76.86 47.44
Support Level $3.46 $2.19
Resistance Level N/A $3.05
Average True Range (ATR) 0.61 0.23
MACD 0.22 -0.01
Stochastic Oscillator 92.05 54.91

Price Performance

Historical Comparison
LCUT
ABOS

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: